Public Consultation for New E-cigarette Regulations in Brazil
According to Brazilian media outlet Conselho, the Brazilian National Health Surveillance Agency (Anvisa) is currently soliciting public opinions on a new draft regulation for e-cigarettes. The consultation and open voting activities will conclude on February 9, 2024.
Brazil's health regulatory agency, Anvisa, approved a proposal for Consultative Public Voting (CP) in December 2023. The proposal, identified as number 1.222/2023, primarily addresses regulations for electronic cigarette devices (DEFs). This new resolution will replace the existing regulations that have been enforced since 2009.
The main points of this proposal include the continued prohibition of the production, import, sale, distribution, storage, and transportation of e-cigarettes, including all types of e-cigarettes. It also explicitly states that any form of public promotion for these products is prohibited, regardless of whether it is targeted towards consumers.
The Brazilian National Health Council (CNS) believes that the proposal by Anvisa is crucial and will contribute to improving the health and well-being of the Brazilian people. They support the revision of current regulations and consider this adjustment to align with the recommendations of the World Health Organization's Framework Convention on Tobacco Control and scientific evidence.
All individuals concerned about this matter have the opportunity to participate and provide feedback by February 9, 2024. Participants can provide simplified feedback by using the dedicated electronic form available on the official Anvisa website, indicating their support for the proposal, or they can provide detailed comments on each clause of the proposal.
The objective of Anvisa's public consultation is to make decisions regarding specific regulations based on solid evidence. Its main goal is to gather critical and well-founded evaluations of the suggested regulations from different sectors of society. Once all suggestions have been received, Anvisa will review all feedback and release a report on the public consultation on its official website.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
